X

CTS History

01Dec

Babesia

In October, due to demand from existing healthcare partners, CTS began testing blood donors for antibody to Babesia microti under an Investigational New Drug exemption as a release test.

About the Author

Related

Assay Conversion

Assay Conversion

In July, the six viral marker assay conversion at CTS Dallas, Phoenix and Tampa laboratories was ach...

Read More >
Pooled Babesia

Pooled Babesia

Transitioned all 5 CTS labs from an investigational new drug (IND) to a licensed pooled Babesia test...

Read More >
Source plasma partners

Source plasma partners

By the end of 2017, CTS has secured three source plasma partners and continues to seek additional pa...

Read More >
Zika Testing

Zika Testing

In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing...

Read More >
CTS Founded

CTS Founded

In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...

Read More >
CTS Business Continuity Plan

CTS Business Continuity Plan

As a component of the CTS Business Continuity Plan, today all 6 labs began using the same laboratory...

Read More >